Lv11
30 积分 2024-09-05 加入
Artificial intelligence in lung cancer diagnosis and prognosis: Current application and future perspective
6小时前
待确认
Artificial intelligence-based multi-omics analysis fuels cancer precision medicine
1天前
已完结
Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review
13天前
已完结
Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
13天前
已完结
Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients
18天前
已完结
Toward personalized treatment approaches for non-small-cell lung cancer
18天前
已完结
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Anticancer Agents
18天前
已完结
Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?
19天前
已完结
Lung cancer: current therapies and new targeted treatments
19天前
已完结
TM2, a novel semi-synthetic taxoid, exerts anti-MDR activity in NSCLC by inhibiting P-gp function and stabilizing microtubule polymerization
19天前
已完结
皖公网安备34019202002308
